Literature DB >> 31515589

[Chondrocalcinosis: idiopathic or manifestation of rare metabolic diseases?]

J Knitza1, A Kleyer2, G Schett2, B Manger2.   

Abstract

Calcification in hyaline and fibrocartilage is caused by the deposition of calcium pyrophosphate dehydrate, commonly referred to as chondrocalcinosis. Clinically, this can lead to arthritis symptoms similar to a gout attack -"pseudogout". Nonetheless, also chronic or asymptomatic disease courses are possible. The prevalence of chondrocalcinosis increases with age. The diagnostic workup of degenerative joint disease, therefore, often reveals calcifications of articular cartilage as harmless incidental findings. However, particularly in patients younger than 60 years of age, chondrocalcinosis can be the symptom of an underlying metabolic disease. This review article highlights these rare diseases and presents unusual manifestations of chondrocalcinosis.

Entities:  

Keywords:  Calcification, physiologic; Calcium pyrophosphate deposition disease; Cartilage, articular; Epidemiology; Osteoarthritis

Mesh:

Substances:

Year:  2019        PMID: 31515589     DOI: 10.1007/s00132-019-03805-7

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  38 in total

1.  Pseudogout attack of the lumbar facet joint: a case report.

Authors:  Takaaki Fujishiro; Yuji Nabeshima; Shinji Yasui; Ikuo Fujita; Shinichi Yoshiya; Hideo Fujii
Journal:  Spine (Phila Pa 1976)       Date:  2002-09-01       Impact factor: 3.468

Review 2.  The role of ANKH in pathologic mineralization of cartilage.

Authors:  Charlene J Williams
Journal:  Curr Opin Rheumatol       Date:  2016-03       Impact factor: 5.006

3.  Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US Veterans.

Authors:  Crystal Kleiber Balderrama; Ann K Rosenthal; Daniel Lans; Jasvinder A Singh; Christie M Bartels
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08-08       Impact factor: 4.794

Review 4.  Therapy for CPPD: Options and Evidence.

Authors:  Mariano Andrés; Francisca Sivera; Eliseo Pascual
Journal:  Curr Rheumatol Rep       Date:  2018-04-19       Impact factor: 4.592

5.  Crowned Dens Syndrome as an Initial Manifestation of Crystalline Deposition Disease.

Authors:  Ryo Koda; Yohei Tsuchida; Kazutaka Yoshizawa; Kazuo Suzuki; Akio Kasai; Tetsuro Takeda; Junichiro James Kazama; Ichiei Narita; Kazukiyo Yoshida
Journal:  Intern Med       Date:  2015-09-15       Impact factor: 1.271

6.  Identification of calcium pyrophosphate deposition disease (CPPD) by ultrasound: reliability of the OMERACT definitions in an extended set of joints-an international multiobserver study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force.

Authors:  Georgios Filippou; Carlo Alberto Scirè; Antonella Adinolfi; Nemanja S Damjanov; Greta Carrara; George A W Bruyn; Tomas Cazenave; Maria Antonietta D'Agostino; Andrea Delle Sedie; Valentina Di Sabatino; Mario Enrique Diaz Cortes; Emilio Filippucci; Frederique Gandjbakhch; Marwin Gutierrez; Daryl K Maccarter; Mihaela Micu; Ingrid Möller Parera; Gaël Mouterde; Mohamed Atia Mortada; Esperanza Naredo; Carlos Pineda; Francesco Porta; Anthony M Reginato; Iulia Satulu; Wolfgang A Schmidt; Teodora Serban; Lene Terslev; Violeta Vlad; Florentin Ananu Vreju; Pascal Zufferey; Panagiotis Bozios; Carmela Toscano; Valentina Picerno; Annamaria Iagnocco
Journal:  Ann Rheum Dis       Date:  2018-03-13       Impact factor: 19.103

Review 7.  Calcium pyrophosphate deposition disease: a review of epidemiologic findings.

Authors:  Abhishek Abhishek
Journal:  Curr Opin Rheumatol       Date:  2016-03       Impact factor: 5.006

8.  EULAR recommendations for calcium pyrophosphate deposition. Part II: management.

Authors:  W Zhang; M Doherty; E Pascual; V Barskova; P-A Guerne; T L Jansen; B F Leeb; F Perez-Ruiz; J Pimentao; L Punzi; P Richette; F Sivera; T Uhlig; I Watt; T Bardin
Journal:  Ann Rheum Dis       Date:  2011-01-20       Impact factor: 19.103

9.  Prevalence of asymptomatic chondrocalcinosis in the pelvis.

Authors:  James Derek Stensby; David A Lawrence; James T Patrie; Cree M Gaskin
Journal:  Skeletal Radiol       Date:  2016-04-02       Impact factor: 2.199

Review 10.  The Role of ANK in Calcium Pyrophosphate Deposition Disease.

Authors:  Elizabeth Mitton-Fitzgerald; Claudia M Gohr; Brittany Bettendorf; Ann K Rosenthal
Journal:  Curr Rheumatol Rep       Date:  2016-05       Impact factor: 4.592

View more
  1 in total

1.  [A patient with inflammatory arthralgia, paraesthesia and atrial fibrillation].

Authors:  D Vossen; V Nehls
Journal:  Z Rheumatol       Date:  2020-02       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.